Annex 5Questions in Population, Intervention, Control, Outcomes (PICO) format
1Effects and safety of iron supplementation in children 24–59 months of age
Should iron supplements be given to children 24–59 months of age to improve health outcomes?
If so, at what dose, frequency and duration of the intervention, and in which settings?
View in own window
Population: | Children 24–59 months of age
Critical
By previous exposure to iron: infants who regularly received an iron supplement within the first 23 months of life versus no iron By malaria (no transmission or elimination achieved, susceptibility to epidemic malaria, year-round transmission with marked seasonal fluctuations, year-round transmission with consideration of Plasmodium falciparum and/or Plasmodium vivax) By use of concurrent antimalarial measures introduced in the study: yes versus no By antimalarial measures implemented by the health system: yes versus no By anaemia status of population: more than 40% versus 40% or less
|
---|
Intervention: | Iron supplementation
Critical
By dose: 2 mg/kg/day versus other By frequency: daily versus weekly versus flexible By duration: 3 months or less versus more than 3 months By nutrient: in combination with other micronutrients or not By targeting: universal versus prescribed
|
---|
Control: |
|
---|
Outcomes: | Critical
|
---|
Setting: | All countries |
---|
2Effects and safety of iron supplementation in children 60 months of age and older
Should iron supplements be given to children 60 months of age and older to improve health outcomes?
If so, at what dose, frequency and duration of the intervention, and in which settings?
View in own window
Population: | Children 60 months of age and older
Critical
By previous exposure to iron: children who regularly received an iron supplement within the first 59 months of life versus no iron By malaria (no transmission or elimination achieved, susceptibility to epidemic malaria, year-round transmission with marked seasonal fluctuations, year-round transmission with consideration of Plasmodium falciparum and/or Plasmodium vivax) By use of concurrent antimalarial measures introduced in the study: yes versus no By antimalarial measures implemented by the health system: yes versus no By anaemia status of population: more than 40% versus 40% or less By individual's status of anaemia: anaemic versus non-anaemic
|
---|
Intervention: | Iron supplementation
Critical
By dose: 2 mg/kg/day versus other By frequency: daily versus weekly versus flexible By duration: 3 months or less versus more than 3 months By nutrient: in combination with other micronutrients or not By targeting: universal versus prescribed
|
---|
Control: |
|
---|
Outcomes: | Critical
|
---|
Setting: | All countries |
---|